Castle Creek Arbitrage’s European Biotech Acquisition Corp. Units EBACU Stock Holding History

Castle Creek Arbitrage’s Portfolio EBACU Stock Details EBACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-32,046	Closed	-$317K	–	626
2022 Q3	$317K	Hold	32,046	–	–	0.02%	360
2022 Q2	$313K	Hold	32,046	–	–	0.02%	362
2022 Q1	$315K	Hold	32,046	–	–	0.02%	389
2021 Q4	$318K	Hold	32,046	–	–	0.02%	427
2021 Q3	$318K	Hold	32,046	–	–	0.02%	382
2021 Q2	$319K	Sell	32,046 -8,513	-21%	-$85.2K	0.02%	416
2021 Q1	$408K	Buy	+40,559	New	+$405K	0.02%	359

Other funds holding EBACU

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

TAM

Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return

Castle Creek Arbitrage's EBACU Position: Q4 2022 in Review

Castle Creek Arbitrage sold out of European Biotech Acquisition Corp. Units (EBACU) in Q4 2022, closing a stake of 32,046 shares — an estimated $317K sold.

Castle Creek Arbitrage first reported a position in EBACU in Q1 2021 and held it in 7 quarters. The position peaked at $408K in Q1 2021. 11 funds tracked by Wall St. Rank hold EBACU as of Q4 2022.

Castle Creek Arbitrage reported no remaining European Biotech Acquisition Corp. Units position as of Q4 2022 after selling out during the quarter.
Castle Creek Arbitrage sold 32,046 European Biotech Acquisition Corp. Units shares in Q4 2022, an estimated $317K.
Castle Creek Arbitrage first reported a position in European Biotech Acquisition Corp. Units in Q1 2021 and held it in 7 quarters.
Castle Creek Arbitrage's European Biotech Acquisition Corp. Units position peaked at $408K in Q1 2021.
11 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Units as of Q4 2022.

Based on Castle Creek Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.